期刊文献+

大明胶囊对2型糖尿病大鼠心肌钾通道KV4.2 mRNA表达的影响 被引量:1

Effect of Daming capsule on the expression of potassium channel KV4.2 mRNA in myocardium of type 2 diabetic rats
下载PDF
导出
摘要 目的探讨大明胶囊对2型糖尿病大鼠心肌钾通道KV4.2 mRNA表达的影响。方法 建立2型糖尿病大鼠模型,筛选 空腹血糖值大于16.7 mmol·L-1的大鼠随机分组:大明胶囊大(187.5 mg·kg-1·d-1)、中(93.8 mg·kg-1·d-1)、小(46.9 mg·kg-1 d-1)剂量组、糖尿病模型组,连续用药14 d,用快速血糖仪测空腹血糖值。提取心肌总RNA,采用逆转录聚合酶链式反应(RT- PCR)的方法,观察大明胶囊治疗后2型糖尿病大鼠心肌钾通道KV4.2 mRNA水平的变化。结果2型糖尿病组大鼠心肌钾通 道KV4.2 mRNA表达低于正常组大鼠(P<0.05),经大明胶囊治疗后的心肌钾通道KV4.2 mRNA表达升高(P<0.05),空腹血 糖也明显下降。结论 大明胶囊对2型糖尿病大鼠有明显的降糖作用,并且可以升高2型糖尿病大鼠心肌钾通道KV4.2 mR- NA的表达。 OBJECTIVE To study the effect of Darning capsule on the expression of potassium channel KV4.2 mRNA in the myocardium of the type 2 diabetic rats.METHODS Type 2 diabetic rat model was established. The mrs, whose plasma glucose were higher than 16,7 retool·L^- 1, were divided into 4 groups randomly: high dose group( 187.5 mg·kg^- 1·d^-1 ), middle dose group(93.8 mg· kg^- 1· d^-1 ), low dose group(46.9 mg·kg^-1·d^-1)and control group. The model rats were given with Daming capsule for 14 d.Plasma glucose was determined, The total RNA from the myocardium of rats was measured by reverse transcription polymerase chain reaction (RT-PCR). The effect of Daming capsule on the expression of potassium channel KV4.2 mRNA in the myocardium of the type 2 diabetic rats was observed. RFSLTS The ex- pression of potassium channel KV4.2 mRNA in the myocardium of the type 2 diabetic rats was lower than that in the normal control group( P 〈 0.05), the expression of potassium channel KV4.2 mRNA in the myocardium was increased after being treated with Daming capsule( P 〈 0.05), the values of plasma glucose distinctly decreased. CONCLUSION Darning capsule decreasd the plasma glucose, and increased the expression of potassium channel KV4.2 mRNA in the myocardium of the type 2 diabetic rats.
出处 《中国药学杂志》 EI CAS CSCD 北大核心 2005年第23期1831-1833,共3页 Chinese Pharmaceutical Journal
基金 国家自然科学基金项目(30371647)黑龙江省科技厅重大项目基金资助(20010101001-00)黑龙江省教育厅课题资助(10531094)黑龙江省攻关项目(GC04C42403)
关键词 大明胶囊 钾通道KV4.2 2型糖尿病 逆转录聚合酶链式反应 Daming capsule potassium channel KV4.2 type 2 diabetic RT-PCR
  • 相关文献

参考文献5

  • 1Qin D, Huang B, Deng L, et al. Downregulation of K^+ channel genes expression in type 1 diabetic cardiomyopathy [J]. Biochem Biophys Res Commun ,2001,283(3) :549.
  • 2Casis O, Gallego M, Iriarte M, et al. Effects of diabetic cardiomyopathy on regional electrophysiologic characteristics of rat ventricle[J].Diabetologia ,2000,43 (1) :101.
  • 3艾静,郭健,张永春,刘欣,何树庄,杨宝峰.四氧嘧啶致大鼠高血糖模型的实验研究[J].哈尔滨医科大学学报,2001,35(2):94-96. 被引量:41
  • 4Ren J, Davidoff AJ. Diabetes rapidly induces contractile dysfunctions in isolated ventricular myocytes[J] .Am J Physiol, 1997,272(1 Pt 2):148.
  • 5Ren J.Attenuated cardiac contractile responsivenesness to insulin-like growth factor Ⅰ in ventricular myocytes from bidbreeding spontaneous diabetic rats[J]. Cardiovasc Res ,2000,46(1): 162.

二级参考文献3

  • 1张均田,现代药理实验方法,1998年,982页
  • 2魏泓,医学实验动物学,1998年,348页
  • 3徐淑云,药理学实验,1985年

共引文献40

同被引文献13

  • 1李小利,李保应,周远大,朱深银.果糖二磷酸钠镁对失血性休克大鼠肾脏的保护作用[J].中国药理学通报,2006,22(9):1137-1140. 被引量:2
  • 2刘颖,焦建杰,娄建石.“Cocktail”探针药物法的研究进展[J].中国临床药理学与治疗学,2006,11(11):1225-1229. 被引量:27
  • 3AI J, ZHAO L M, YANG B F, et al. A randomized, multicentre, openlabel, parallelgroup trial to compare the efficacy and safety profile of Daming Capsule in patients with hypercholesterolemia[J].Phytother Res, 2009, 23(7):1039-1042.
  • 4AI J, YAN X X, YANG B F, et al. The protective effect of Daming capsule on heart function in streptozocininduced diabetic rats with hyperlipidemia[J].Biol Pharm Bull, 2009, 32(8):1354-1358.
  • 5CDER, CBER Guidance for Industry:Drug interaction studies—study design, data analysis and implications for dosing and labeling (Draft guidance) [EB/OL] USA, Food and Drug Administration, 2006:1-51 [20060908], http://wwwfdagov/cder/guidance.
  • 6LIUGF ZHENLM.How useful is the “cocktail approach” for evaluating the effects of Chinese traditional medicine on cytochrome P450.医药导报,2009,28(8):1049-1052.
  • 7FANHR HEF LIUCX. Research progress of the “cocktail approach” for cytochrome P450.中国药学杂志,2006,41(14):1045-1048.
  • 8MAKINO T, NAGAKI T, KOMATSU K, et al. Pharmacokinetic interactions between Japanese traditional Kampo medicine and modern medicine (IV)Effect of Kamisyoyosan and Tokisyakuyakusan on the pharmacokinetics of etizolam in rats[J].Biol Pharm Bull, 2005, 28(2):280-284.
  • 9ZHOUHH, ZEENT, JAMES F Cocktail approaches and strategies in drug development:valuable tool or flawed science[J].J Clin Pharmacol, 2004, 44(2):120-143.
  • 10TANA KA E, KURATA N, YASUHARA H How useful is the“cocktail approach” for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo[J].Clin Pharm Ther, 2003, 28(3):157-165.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部